Skip to main navigation Skip to search Skip to main content

Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors - A review

  • Akira Sawaki
  • , Kenji Yamao

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors - A review'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases